No Data
Express News | Merck and Orion announced that Opevesostat will be exclusively licensed by Merck.
Market Whales and Their Recent Bets on MRK Options
Investors with a lot of money to spend have taken a bearish stance on Merck & Co (NYSE:MRK).And retail traders should know.We noticed this today when the positions showed up on publicly available opti
Express News | Merck Shares up 3.8%
Orion Upgrades FY24 Outlook After Modifying Agreement With Merck & Co
Orion (ORNAV.HE, ORNBV.HE) upwardly revised its full-year outlook after its development and commercialization deal with US-based Merck & Co was converted into a global license for the latter, accordin
Merck, Orion Convert Collaboration Into Exclusive License
By Colin Kellaher Merck & Co. and Finland's Orion have agreed to convert a 2022 co-development and co-commercialization agreement into an exclusive global license for Merck. The companies on Monday
Express News | N-Power Medicine: Collaborates With Merck to Expand Oncologist and Patient Access to Clinical Trials